Brind.

Pacira BioSciences, Inc. issued a press release from Brisbane regarding their ASCEND clinical study.

2 reports, 2 independent Updated Jun 30
Gone quiet
Reports
2
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Pacira BioSciences, Inc. issued a press release from Brisbane regarding their ASCEND clinical study.

How it developed

Newest first. Tap a step to see who reported it.
  1. Pacira transitioned the manufacturing process for its ASCEND clinical study.Sub-event
  2. Pacira BioSciences, Inc. provided an update on their ASCEND clinical study from Brisbane.1 source

Coverage

Newest first; wire copies grouped
  • manilatimes.net
  • GlobeNewswirePacira BioSciences Reports Second Quarter 2025 Financial Results -- Solid execution across corporate, clinical and commercial initiatives -- -- Several key milestones advance 5x30 path to growth -- -